Business
Fortress Biotech to Ring Nasdaq Stock Market Closing Bell on December 21
NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring,
About this update from Fortress Biotech, Inc.
[{"type":"text","content":"NEW YORK, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, announced that Lindsay A. Rosenwald, M.D., Chairman and Chief Executive Officer, will ring the closing bell at the Nasdaq MarketSite in Times Square today, Tuesday, December 21, 2021 at 4:00 p.m. EST. Fortress is celebrating its 10-year anniversary as a publicly traded company on the Nasdaq Stock Market. Lindsay A. Rosenwald, M.D., Fortress’ Chairman and Chief Executive Officer, said, “We are honored to celebrate the 10-year anniversary of Fortress’ Nasdaq listing by ringing the closing bell today. Since the company’s management team took the helm in 2014, Fortress and our partner companies have built a growing portfolio of seven marketed dermatologic pharmaceutical products and more than 30 product candidates in our pipeline across multiple therapeutic categories including oncology, gene therapy, dermatology and rare diseases. We believe that our diverse pipeline creates multiple revenue streams demonstrated by our recent quarterly record with a net revenue increase of 123% year-over-year to $21.1 million. In addition, in October 2021 Fortress received upfront cash proceeds of approximately $56.9 million from consummation of the sale of partner company Caelum Biosciences to AstraZeneca plc. Our unique approach is aimed at minimizing risk and allowing Fortress to create long-term value for our shareholders through our revenue, sales, royalties, equity value, monetization opportunities and potential priority review voucher sales. We expect to continue to achieve significant clinical and corporate milestones as we develop new treatment options for patients in need.” A live stream of the Nasdaq Closing Bell will be available at: https://www.nasdaq.com/marketsite/bell-ringing-ceremony. About Fortress Biotech Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors, based on percentages of fiscal year revenue growth over three...